Results 1 to 10 of about 721,295 (295)

Semaglutide in Overweight and Obese patients: Cardiovascular and/or Renal Metabolic Benefits

Revista Colombiana de Nefrología, 2022
We have read the article published by Kadowaki, et al. 1 “Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes mellitus in an East Asian population (STEP 6): A randomized, double blind, double dummy, placebo ...
Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Jose Cabrales, Juan Diego Montejo-Hernández   +3 more
doaj   +1 more source

Additional Considerations in the Treatment of Diabetic Nephropathy Based on the KDOQI Clinical Practice Guideline

Revista Colombiana de Nefrología, 2022
Obesity is a risk factor for the development and progression of CKD, which has been shown in numerous studies. The mechanism of how this occurs is not completely understood, but several putative mechanisms proposed via adiposity, include low adiponectin ...
Jorge Rico Fontalvo, Juan David Montejo Hernández, Rodrigo Daza Arnedo, Jose Cabrales   +3 more
doaj   +1 more source

Interactions between hypertension and inflammatory tone and the effect on blood pressure and outcomes in patients with COVID‐19

The Journal of Clinical Hypertension, 2021
Arterial hypertension represented one of the most common comorbidities in patients with COVID‐19. However, the impact of hypertension on outcome in COVID‐19 patients is not clear.
Jacques Amar, Nicolas Touront, Antoine M. Ciron, Caroline Pendaries   +3 more
doaj   +1 more source

Impact of concomitant COVID-19 on the outcome of patients with acute myocardial infarction undergoing coronary artery angiography

Frontiers in Cardiovascular Medicine, 2022
BackgroundThe impact of COVID-19 on the outcome of patients with MI has not been studied widely. We aimed to evaluate the relationship between concomitant COVID-19 and the clinical course of patients admitted due to acute myocardial infarction (MI ...
Michał Terlecki, Wiktoria Wojciechowska, Marek Klocek, Agnieszka Olszanecka, Adam Bednarski, Tomasz Drożdż, Christopher Pavlinec, Paweł Lis, Maciej Zając, Jakub Rusinek, Zbigniew Siudak, Stanisław Bartuś, Marek Rajzer   +12 more
doaj   +1 more source

Outcome in Elderly Patients with Anca – Associated Glomerulonephritis Managed with Immunosuppressive Treatment

Acta Clinica Croatica, 2021
The most common cause of rapidly progressive glomerulonephritis in elderly, antineutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN), demands immunosuppressive therapy (IS) regimen in a multi-morbid disease burdened population.
Karlo Kurtov, Mario Laganović, Sandra Karanović, Živka Dika, Ema Ivandić, Marijana Živko, Jelena Kos, Margareta Fištrek, Bojan Jelaković, Ivana Vuković Brinar   +9 more
doaj   +1 more source

Selected matrix metalloproteinases activity and hypertension-mediated organ damage in relation to uric acid serum level

Cardiology Journal, 2021
BACKGROUND: Atherosclerosis is as a systemic inflammatory disease associated with the activationof many mediators, including matrix metalloproteinases (MMPs), and may be amplified by abnormal high serum uric acid (UA) concentration (hyperuricemia, HU ...
Krystian Gruszka, Marek Rajzer, Tomasz Drożdż, Wiktoria Wojciechowska, Tomasz Pizoń, Kamila Migacz-Gruszka, Danuta Czarnecka   +6 more
doaj   +1 more source

Unattended automated office blood pressure measurement — current evidence and the role in clinical practice

Arterial Hypertension, 2021
Arterial hypertension is a leading preventable cardiovascular risk factor. The definition and thresholds for the diagnosis of hypertension vary between European and American guidelines.
Marek Stopa, Agnieszka Olszanecka, Marek Rajzer   +2 more
doaj   +1 more source

Dietary sodium sources in hypertensive patients

Arterial Hypertension, 2023
BACKGROUND: Reducing dietary salt intake is the method recommended by the experts as the non-pharmacological treatment of hypertension. The purpose of this study was to evaluate the amount of dietary sodium intake by hypertensive patients and to analyze ...
Dariusz Stąpor, Błażej Kaleta, Weronika Olesiak, Beata Podlejska, Marek Rajzer, Katarzyna Stolarz-Skrzypek   +5 more
doaj   +1 more source

Myocardial infarction caused by Graves’ disease

Endokrynologia Polska, 2021
Not required for Clinical Vignette.
Marek Kuch, Magdalena Rostek, Marek Chmielewski, Monika Bargieł   +3 more
doaj   +1 more source

Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland

Frontiers in Cardiovascular Medicine, 2023
BackgroundAtrial fibrillation (AF) is a common arrhythmia with increasing prevalence with respect to age and comorbidities. AF may influence the prognosis in patients hospitalized with Coronavirus disease 2019 (COVID-19).
Michał Terlecki, Wiktoria Wojciechowska, Marek Klocek, Tomasz Drożdż, Maryla Kocowska-Trytko, Paweł Lis, Christopher Pavlinec, Jan W. Pęksa, Michał Kania, Zbigniew Siudak, Andrzej Januszewicz, Reinhold Kreutz, Maciej Małecki, Tomasz Grodzicki, Marek Rajzer, CraCov HHS Investigators   +15 more
doaj   +1 more source